Literature DB >> 16581270

A novel approach to data processing of the QT interval response in the conscious telemetered beagle dog.

Anna Ollerstam1, Anna H Persson, Sandra A G Visser, J Magnus Fredriksson, Tomas Forsberg, Lars B Nilsson, Göran Eklund, Stig Johan Wiklund, Johan Gabrielsson, Göran Duker, Ahmad Al-Saffar.   

Abstract

INTRODUCTION: Drug-induced QT interval prolongation may lead to ventricular arrhythmias. The aim of the study was to optimize QT interval data processing to quantify drug-induced QT interval prolongation in the telemetry instrumented conscious dog model.
METHODS: The test substances cisapride, dofetilide, haloperidol, and terfenadine and corresponding vehicles were given to male and female beagle dogs during two consecutive 90-min intravenous infusions. Cardiovascular parameters were recorded for 24 h and exposure to the drugs was measured. The delayed response in the QT interval after an abrupt change in heart rate was investigated. Eight mathematical models to describe the QT interval-heart rate relationship were compared and different sets of covariates were used to quantify the drug-induced effect on the QT interval.
RESULTS: After an abrupt decrease in heart rate, a 75% adaptation of the QT interval was reached after 54+/-9 s. A linear model was preferred to correct the drug-induced effect on the QT interval for heart rate, vehicle effect, serial correlation, plasma concentration and time of day. All test substances significantly prolonged the QT interval. DISCUSSION: To optimize the processing of QT interval data, the delay in QT interval response after an abrupt change in heart rate should be considered. The QT interval-heart rate relationship and vehicle response were individual-specific and corrections were therefore made individually. When estimating the drug-induced effect on the QT interval it is considered advantageous to use plasma concentration as a covariate, as well as adjusting for vehicle effect and serial correlation in measurements. The conscious dog model detected significant increases in the QT interval for all test substances investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581270     DOI: 10.1016/j.vascn.2006.02.009

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  8 in total

1.  Model-based evaluation of drug-induced QTc prolongation for compounds in early development.

Authors:  Vincent F S Dubois; Huixin Yu; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation.

Authors:  S Y A Cheung; J Parkinson; U Wählby-Hamrén; C D Dota; Å M Kragh; L Bergenholm; T Vik; T Collins; C Arfvidsson; C E Pollard; H K Tomkinson; B Hamrén
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-05-07       Impact factor: 2.745

3.  Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.

Authors:  Raja Venkatasubramanian; Teresa A Collins; Lawrence J Lesko; Jerome T Mettetal; Mirjam N Trame
Journal:  Br J Pharmacol       Date:  2020-06-18       Impact factor: 8.739

4.  Safety reassessment of cinobufotalin injection: new findings into cardiotoxicity.

Authors:  Min Li; Xijie Wang; Yunliang Qiu; Yizhe Zhang; Xueying Pan; Naping Tang; Tao Chen; Bing Ruan; Shuming Shao; Liang He; Hua Li; Jing Ma
Journal:  Toxicol Res (Camb)       Date:  2020-06-12       Impact factor: 3.524

5.  Translating QT interval prolongation from conscious dogs to humans.

Authors:  Vincent F S Dubois; Giovanni Smania; Huixin Yu; Ramona Graf; Anne S Y Chain; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

6.  Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: prediction from in vitro human ether-à-go-go-related gene binding and functional inhibition assays and conscious dog studies.

Authors:  V F S Dubois; E Casarotto; M Danhof; O Della Pasqua
Journal:  Br J Pharmacol       Date:  2016-09-07       Impact factor: 8.739

7.  On the potential of in vitro organ-chip models to define temporal pharmacokinetic-pharmacodynamic relationships.

Authors:  Christopher W McAleer; Amy Pointon; Christopher J Long; Rocky L Brighton; Benjamin D Wilkin; L Richard Bridges; Narasimham Narasimhan Sriram; Kristin Fabre; Robin McDougall; Victorine P Muse; Jerome T Mettetal; Abhishek Srivastava; Dominic Williams; Mark T Schnepper; Jeff L Roles; Michael L Shuler; James J Hickman; Lorna Ewart
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

8.  Assessment of Interspecies Differences in Drug-Induced QTc Interval Prolongation in Cynomolgus Monkeys, Dogs and Humans.

Authors:  V F S Dubois; W E A de Witte; S A G Visser; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.